Hancock Whitney Corp Biomarin Pharmaceutical Inc Transaction History

Hancock Whitney Corp

$2.92 Billion
Q2 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Nov 13, 2023	SELL	$86.68 - $100.3 $11,441 - $13,239	-132 Reduced 5.22%	2,398 $207,000
Q2 2023 Aug 10, 2023	SELL	$86.68 - $100.3 $11,441 - $13,239	-132 Reduced 5.22%	2,398 $208,000
Q1 2023 Nov 13, 2023	BUY	$87.74 - $117.27 $1,754 - $2,345	20 Added 0.8%	2,530 $246,000
Q1 2023 May 16, 2023	BUY	$87.74 - $117.27 $1,754 - $2,345	20 Added 0.8%	2,530 $246,000
Q4 2022 Nov 13, 2023	BUY	$80.93 - $108.63 $9,064 - $12,166	112 Added 4.67%	2,510 $259,000
Q2 2022 Aug 08, 2022	BUY	$71.48 - $86.85 $179,414 - $217,993	2,510 New	2,510 $208,000
Q1 2022 May 12, 2022	SELL	$74.28 - $92.69 $186,442 - $232,651	-2,510 Closed	0 $0
Q4 2021 Jan 25, 2022	SELL	$71.72 - $91.47 $5,737 - $7,317	-80 Reduced 3.09%	2,510 $222,000
Q3 2021 Nov 04, 2021	SELL	$74.77 - $85.47 $34,244 - $39,145	-458 Reduced 15.03%	2,590 $200,000
Q2 2021 Aug 09, 2021	BUY	$75.51 - $84.79 $5,210 - $5,850	69 Added 2.32%	3,048 $254,000
Q1 2021 May 14, 2021	SELL	$74.73 - $90.69 $34,450 - $41,808	-461 Reduced 13.4%	2,979 $225,000
Q4 2020 Feb 09, 2021	SELL	$72.61 - $90.2 $15,102 - $18,761	-208 Reduced 5.7%	3,440 $302,000
Q3 2020 Nov 05, 2020	SELL	$71.87 - $131.03 $5,174 - $9,434	-72 Reduced 1.94%	3,648 $278,000
Q2 2020 Jul 30, 2020	SELL	$79.55 - $124.22 $24,421 - $38,135	-307 Reduced 7.62%	3,720 $459,000
Q1 2020 May 08, 2020	BUY	$71.37 - $96.85 $6,566 - $8,910	92 Added 2.34%	4,027 $340,000
Q4 2019 Feb 06, 2020	SELL	$64.27 - $86.37 $57,778 - $77,646	-899 Reduced 18.6%	3,935 $333,000
Q3 2019 Oct 29, 2019	SELL	$67.4 - $85.11 $9,840 - $12,426	-146 Reduced 2.93%	4,834 $326,000
Q2 2019 Aug 29, 2019	SELL	$80.35 - $93.9 $9,320 - $10,892	-116 Reduced 2.28%	4,980 $427,000
Q1 2019 May 13, 2019	SELL	$84.2 - $98.62 $114,259 - $133,827	-1,357 Reduced 21.03%	5,096 $453,000
Q4 2018 Feb 15, 2019	SELL	$80.14 - $106.07 $36,303 - $48,049	-453 Reduced 6.56%	6,453 $549,000
Q3 2018 Nov 14, 2018	BUY	$93.92 - $105.72 $648,611 - $730,102	6,906 New	6,906 $670,000

Others Institutions Holding BMRN

# of Institutions

632

Shares Held

185M

Call Options Held

1.63M

Put Options Held

1.2M

Black Rock Inc. New York, NY

22.7M
Shares

$1.6 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19M
Shares

$1.34 Billion
0.03% of portfolio
Primecap Management CO Pasadena, CA

18.8M
Shares

$1.32 Billion
1.14% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$979 Million
0.72% of portfolio
Capital Research Global Investors Los Angeles, CA

9.69M
Shares

$681 Million
0.18% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hancock Whitney Corp, based on Form 13F filings with the SEC.

News

Stay updated on Hancock Whitney Corp with notifications on news.

Account